APAF1 and Parkinson disease: Apaf-1(apoptotic peptidase activating factor) was reported as a potential drug target for neurodegenerative diseases and Apaf-1 dominant negative inhibitor can prevent MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease(27).